(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
College students are now slightly less likely to experience severe depression, research shows – but the mental health crisis is far from over - 2Step by step instructions to Explore Assessment Ramifications of Disc Rates
- 3Kissing is an ‘evolutionary conundrum.’ Scientists just mapped its unexpected origins
- 4Trump declares Christmas Eve and Dec. 26 federal holidays: What does that mean?
- 5Benedict Cumberbatch takes on something even Sherlock can’t solve: male grief
- IDF strikes Shiraz petrochemical site, releases footage of attacks on Iranian air defenses
- Astronomers discover never-before-seen celestial object: "Cloud 9"
- Where is Santa right now? NORAD tracks his 2025 Christmas Eve flight.
- The Best 20 Tunes that Characterized an Age
- NASA's Artemis 2 moon launch may be visible from Florida and southern Georgia today. Here's when to look
- Lucrative Positions in the Advancing Position Market of 2024
- Sixteen Kenyans missing in Russia after army recruitment
- What causes RFK Jr.’s strained and shaky voice? A neurologist explains this little-known disorder
- ‘Dying of thirst’: Inside Gaza’s al-Mawasi water crisis
